An analysis of major cardiology journals in both the U.S. and Europe underlines the stark sex gap in cardiology, revealing that, between 1998 and 2018, there were no women editors-in-chief for U.S. general cardiology journals and only one woman editor-in-chief for a European journal.

A study published in the European Heart Journal on Feb. 18 suggests healthcare expenditures in Europe would skyrocket if local systems adopted experts’ latest guidelines for cholesterol-lowering treatment.

Many Americans who can’t afford prescription insulin for their diabetes are turning to unregulated, illegal markets for discounted products, researchers reported in JAMA Internal Medicine this month.

Some 20% of children have high blood pressure, WBAL-TV reported Feb. 17.

A Canadian clinical psychologist is repurposing a beta-blocker to ease the pain of emotional trauma, the BBC reports.

Research out of the Yale School of Public Health in New Haven, Conn., has revealed a relationship between rosiglitazone, a type 2 diabetes drug, and heart disease.

The U.S. FDA on Feb. 6 granted Breakthrough Device Designation to medical device developer Aria CV, Inc., for its Aria CV Pulmonary Hypertension System.

People who begin taking antihypertensive drugs or lipid-lowerers like statins are more likely than non-initiators to become obese and physically inactive, a JAHA study has found—but they’re also more likely to quit smoking and keep their alcohol intake in check.